👩‍🔬 @carogarred findings presented at the @HerlevGentofte research symposium are thought-provoking. She's shedding light on the lack of improvements in risk of death in octogenarians 👵 with heart failure 💔 compared to younger patients. 🧐 Important insights 🏥

Exciting moment at the @HerlevGentofte research symposium! Regitze Hein is revealing the benefits of a shorter time ⏱️ to ablation for patients with atrial fibrillation. ⚡️

🌟 Noor Abassi presenting at the @HerlevGentofte research symposium. She's delving into the risk of death in a #HeartFailure population, categorizing them by their #frailty scores. Valuable research to enhance care for vulnerable patients.

Exciting presentation at the @HerlevGentofte research symposium. Marte Austreim is shedding light on the risk of death and adverse effects for heart failure (#HF) patients with and without atrial fibrillation (#AF). 🏥 Important insights for better patient care💡👩‍🔬

Exciting new addition to the Research Weekend for Herlev-Gentofte. Hyde Park session! 🌟 Innovative and interactive short presentations by our talented young researchers are lighting up the event 🚀 @cardio_dk

In this cross-sectional nationwide @LancetLongevity study @MariamElmegaard and @mortschou et al showed #frailty was associated with a ⬇️lower probability of SGLT2-inhibitor or GLP-1 receptor-agonist initiation, despite their benefits Free 🔗 thelancet.com/journals/lanhl…

👏@MariamElmegaard presented her impressive study in light of the new ESC 2023 guidelines for the management of CVD in T2D. Should we focus more on preventing cardiorenal disease in patients without established CVD and CKD 🤔? #ESCCongress @cardio_dk #DCS_ESC23 @mortschou